Bjarne Corydon er flov over at have løbet fra løftet om øremærket barsel, Karen Ellemann krummer tæer over, at Godhavnsdrengene ikke fik en undskyldning på hendes vagt, og Poul Nyrup Rasmussen fortæll ...
By contrast, Novo Nordisk is both the developer and seller of Wegovy, while Viking Therapeutics's VK2735 has posted impressive results in testing and is now in the later stages of development. Wegovy ...
Novo Nordisk faces challenges but its pipeline remains strong. Find out why NVO stock could deliver high double-digit returns ...
New York, New York-- (Newsfile Corp. - February 9, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Novo Nordisk (NYSE: NVO) and certain ...
Novo Nordisk's hemophilia A drug Mim8 shows success in pediatric trial, Mim8 could compete with Roche's Hemlibra, with plans ...
Thin is in og fedmemedicin sikrede Novo Nordisk rekordomsætning på over 100 milliarder i 2024. Er det positive kropsideal virkelig en utopi?
Regeringen og Novo Nordisk Fonden er netop blevet enige om, hvordan de ti milliarder kroner, fonden har givet til den grønne ...
Trademark prosecution data reveals how the rival healthcare companies are ensuring exclusivity internationally for their ...
Toneangivende økonomer efterlyser, at man fra politisk hold åbent fortæller, at de markant øgede forsvarsudgifter kommer med ...
Udenrigsminister Lars Løkke Rasmussen (M) præsenterer torsdag en ny strategi for maritim sikkerhed sammen med ...
Novo Nordisk emissions grew 23% in 2024, the company said on Wednesday, and will keep rising through the end of the decade as ...
Novo Nordisk reported strong sales growth for its Wegovy and Ozempic drugs, while its 2025 guidance topped expectations. Shares in Novo, one of Europe's largest listed companies, rallied in the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback